Literature DB >> 16189021

Conjugation of lentivirus to paramagnetic particles via nonviral proteins allows efficient concentration and infection of primary acute myeloid leukemia cells.

Lucas Chan1, Darren Nesbeth, Taylor Mackey, Joanna Galea-Lauri, Joop Gäken, Francisco Martin, Mary Collins, Ghulam Mufti, Farzin Farzaneh, David Darling.   

Abstract

Nonviral producer cell proteins incorporated into retroviral vector surfaces profoundly influence infectivity and in vivo half-life. We report the purification and concentration of lentiviral vectors using these surface proteins as an efficient gene transduction strategy. Biotinylation of these proteins and streptavidin paramagnetic particle concentration enhances titer 400- to 2,500-fold (to 10(9) CFU/ml for vesicular stomatitis virus G protein and 5 x 10(8) for amphotropic murine leukemia virus envelope). This method also uses newly introduced membrane proteins (B7.1 and DeltaLNGFR) directed to lentiviral surfaces, allowing up to 17,000-fold concentrations. Particle conjugation of lentivirus allows facile manipulation in vitro, resulting in the transduction of 48 to 94% of human acute myeloid leukemia blasts.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16189021      PMCID: PMC1235865          DOI: 10.1128/JVI.79.20.13190-13194.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Packaging cell line DNA contamination of vector supernatants: implication for laboratory and clinical research.

Authors:  J Chen; L Reeves; N Sanburn; J Croop; D A Williams; K Cornetta
Journal:  Virology       Date:  2001-03-30       Impact factor: 3.616

2.  Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo.

Authors:  F Scherer; M Anton; U Schillinger; J Henke; C Bergemann; A Krüger; B Gänsbacher; C Plank
Journal:  Gene Ther       Date:  2002-01       Impact factor: 5.250

3.  Streptavidin paramagnetic particles provide a choice of three affinity-based capture and magnetic concentration strategies for retroviral vectors.

Authors:  C Hughes; J Galea-Lauri; F Farzaneh; D Darling
Journal:  Mol Ther       Date:  2001-04       Impact factor: 11.454

4.  Concentration of viral vectors by co-precipitation with calcium phosphate.

Authors:  L Pham; H Ye; F L Cosset; S J Russell; K W Peng
Journal:  J Gene Med       Date:  2001 Mar-Apr       Impact factor: 4.565

5.  Lipid rafts and pseudotyping.

Authors:  W F Pickl; F X Pimentel-Muiños; B Seed
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

6.  Engraftment of NOD/SCID mice with human CD34(+) cells transduced by concentrated oncoretroviral vector particles pseudotyped with the feline endogenous retrovirus (RD114) envelope protein.

Authors:  J Gatlin; M W Melkus; A Padgett; P F Kelly; J V Garcia
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

7.  Differential incorporation of CD45, CD80 (B7-1), CD86 (B7-2), and major histocompatibility complex class I and II molecules into human immunodeficiency virus type 1 virions and microvesicles: implications for viral pathogenesis and immune regulation.

Authors:  M T Esser; D R Graham; L V Coren; C M Trubey; J W Bess; L O Arthur; D E Ott; J D Lifson
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

8.  Jaagsiekte sheep retrovirus Env protein stabilizes retrovirus vectors against inactivation by lung surfactant, centrifugation, and freeze-thaw cycling.

Authors:  D A Coil; J H Strickler; S K Rai; A D Miller
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

9.  Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range.

Authors:  Winfried R Beyer; Manfred Westphal; Wolfram Ostertag; Dorothee von Laer
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

10.  Fusagene vectors: a novel strategy for the expression of multiple genes from a single cistron.

Authors:  J Gäken; J Jiang; K Daniel; E van Berkel; C Hughes; M Kuiper; D Darling; M Tavassoli; J Galea-Lauri; K Ford; M Kemeny; S Russell; F Farzaneh
Journal:  Gene Ther       Date:  2000-12       Impact factor: 5.250

View more
  9 in total

1.  Rapid dissociation of HIV-1 from cultured cells severely limits infectivity assays, causes the inactivation ascribed to entry inhibitors, and masks the inherently high level of infectivity of virions.

Authors:  Emily J Platt; Susan L Kozak; James P Durnin; Thomas J Hope; David Kabat
Journal:  J Virol       Date:  2009-12-30       Impact factor: 5.103

2.  Faster generation of hiPSCs by coupling high-titer lentivirus and column-based positive selection.

Authors:  Emily Dick; Elena Matsa; Lorraine E Young; David Darling; Chris Denning
Journal:  Nat Protoc       Date:  2011-05-05       Impact factor: 13.491

Review 3.  The application of nanoparticles in gene therapy and magnetic resonance imaging.

Authors:  Fernando Herranz; Elena Almarza; Ignacio Rodríguez; Beatriz Salinas; Yamilka Rosell; Manuel Desco; Jeff W Bulte; Jesús Ruiz-Cabello
Journal:  Microsc Res Tech       Date:  2011-04-11       Impact factor: 2.769

4.  Microfluidic devices with templated regular macroporous structures for HIV viral capture.

Authors:  Krissada Surawathanawises; Kathryn Kundrod; Xuanhong Cheng
Journal:  Analyst       Date:  2016-03-07       Impact factor: 4.616

5.  Micropatterned macroporous structures in microfluidic devices for viral separation from whole blood.

Authors:  Krissada Surawathanawises; Victoria Wiedorn; Xuanhong Cheng
Journal:  Analyst       Date:  2017-05-30       Impact factor: 4.616

Review 6.  Magnetically enhanced nucleic acid delivery. Ten years of magnetofection-progress and prospects.

Authors:  Christian Plank; Olivier Zelphati; Olga Mykhaylyk
Journal:  Adv Drug Deliv Rev       Date:  2011-08-26       Impact factor: 15.470

7.  Affinity Sedimentation and Magnetic Separation With Plant-Made Immunosorbent Nanoparticles for Therapeutic Protein Purification.

Authors:  Matthew J McNulty; Anton Schwartz; Jesse Delzio; Kalimuthu Karuppanan; Aaron Jacobson; Olivia Hart; Abhaya Dandekar; Anatoli Giritch; Somen Nandi; Yuri Gleba; Karen A McDonald
Journal:  Front Bioeng Biotechnol       Date:  2022-04-27

8.  Optimised concentration and purification of retroviruses using membrane chromatography.

Authors:  D J McNally; D Darling; F Farzaneh; P R Levison; N K H Slater
Journal:  J Chromatogr A       Date:  2014-03-15       Impact factor: 4.759

Review 9.  Lentiviral Vector Bioprocessing.

Authors:  Christopher Perry; Andrea C M E Rayat
Journal:  Viruses       Date:  2021-02-09       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.